FZD2 Knockout PANC-1 Cell Line

The choice depends on whether you are studying FZD2 (Frizzled-2)'s role as a Wnt receptor or its functions in pancreatic cancer epithelial-mesenchymal transition (EMT) and metastasis. The Knockout line is the standard tool for asking whether FZD2 is required for these processes — FZD2 is one of ten Frizzled family Wnt receptors (FZD1-10) that, together with LRP5/6 co-receptors, transduce canonical Wnt signaling; FZD2 has emerged as particularly important in EMT-driven cancer progression and pancreatic cancer biology. Overexpression is useful for studying FZD2 gain-of-function effects. Important consideration: Frizzled family members share substantial Wnt ligand binding — single FZD2 knockout may show modest phenotypes if other Frizzleds compensate. Rescue with wild-type or Wnt-binding-deficient FZD2 is the standard specificity control. The knockout is valuable for studying pancreatic cancer EMT-driven progression, FZD2-targeted therapeutic antibodies (vantictumab is anti-FZD), and emerging Wnt pathway-targeted cancer drug development.

Primary applications: • Canonical Wnt signaling: TCF/LEF reporter and Wnt target gene (AXIN2, LGR5) expression analysis following Wnt ligand stimulation in FZD2-null pancreatic cancer cells. • Non-canonical Wnt signaling: Wnt/PCP and Wnt/Ca²⁺ pathway analysis given FZD2's role in non-canonical Wnt. • EMT in pancreatic cancer: EMT markers (E-cadherin, N-cadherin, vimentin, SNAIL) and migration/invasion assays given FZD2's role in EMT-driven cancer progression. • Frizzled-targeted antibody specificity: critical genetic control for vantictumab (OMP-18R5, anti-Frizzled) and other Wnt pathway-targeted antibodies. EDITGENE recommends this pancreatic cancer model for researchers investigating FZD2-driven EMT, pancreatic cancer Wnt biology, and Frizzled-targeted cancer therapeutics.

Yes. FZD2 rescue experiments require attention to seven-transmembrane GPCR architecture: • Construct design: use a codon-modified FZD2 sequence with a small intracellular C-terminal tag (FLAG, HA). FZD2 has extracellular cysteine-rich domain (CRD, Wnt binding), seven-transmembrane region, and intracellular tail — preserve all elements. • Wnt-binding-deficient rescue: CRD domain mutations abolish Wnt ligand binding. • Dishevelled-binding-deficient rescue: intracellular tail KTxxxW motif mutations disrupt DVL recruitment. • Functional readout: rescue should restore Wnt-induced TCF/LEF reporter activity and EMT-related phenotypes. PANC-1-specific considerations: • PANC-1 is a human pancreatic ductal adenocarcinoma cell line (KRAS G12D mutant, p53 mutant) — a relevant model for PDAC biology and Wnt pathway research in pancreatic cancer. • Lentiviral transduction is supported with moderate efficiency. • PANC-1's KRAS-mutant epithelial origin makes it complementary to AsPC-1 (KRAS-mutant ascites-derived) for pancreatic cancer studies.